» Articles » PMID: 31792034

Fractures and Survival in Multiple Myeloma: Results from a Population-based Study

Overview
Journal Haematologica
Specialty Hematology
Date 2019 Dec 4
PMID 31792034
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple myeloma causes lytic bone lesions and fractures. The impact of fractures on multiple myeloma (MM) survival is unclear. The aim of this study was to evaluate the effect of fractures on survival in MM using data from MM patients diagnosed in Sweden in the years 1990-2013, identified from the Swedish Cancer Registry. Information on date of birth, MM diagnosis, fractures, and death was collected from central registries. A Cox regression model was used to compare survival in patients with and without a fracture at MM diagnosis and another Cox model was used with fracture as a time-dependent variable to assess the effect of fracture on survival after MM diagnosis. Results were adjusted for age, sex, year of diagnosis, and previous fractures. A total of 14,013 patients were diagnosed with MM during the study, of whom 1,213 (8.7%) were diagnosed with a fracture at MM diagnosis, and 3,235 (23.1%) after diagnosis. Patients with a fracture at diagnosis were at a significantly increased risk of death (hazard ratio=1.28; 95% confidence interval: 1.19-1.37). The risk of death was significantly increased in patients with a fracture after MM diagnosis (2.00; 1.90-2.10). The impact of fractures on survival did not change significantly between the two calendar periods 1990-1999 and 2000-2013 (0.98; 0.89-1.08). Our large study shows that MM patients with fractures are at a significantly increased risk of dying compared to those without fractures, which stresses the importance of preventing bone disease in MM.

Citing Articles

The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients.

Huang L, Zhong Y, Chen Q, He D, Zheng G, Yang Y Cancer Biol Ther. 2024; 25(1):2403205.

PMID: 39295128 PMC: 11649219. DOI: 10.1080/15384047.2024.2403205.


First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis.

Eskelinen V, Nivakoski E, Launonen K, Partanen A, Kakko S, Kuusisto M Hematol Rep. 2024; 16(3):529-540.

PMID: 39189247 PMC: 11348108. DOI: 10.3390/hematolrep16030051.


Atypical Presentation of Multiple Myeloma Affecting Appendicular Skeleton Associated with Pathological Neck of Femur and Proximal Humerus Fractures - A Case Report.

Avhad T, Bhangde S J Orthop Case Rep. 2024; 14(8):174-178.

PMID: 39157502 PMC: 11327678. DOI: 10.13107/jocr.2024.v14.i08.4690.


Proximal femoral multiple myeloma pathological fractures, impending and actual fractures - a patient survival study.

Hershkovich O, Sakhnini M, Barkay G, Liberman B, Friedlander A, Lotan R BMC Cancer. 2024; 24(1):917.

PMID: 39080587 PMC: 11290202. DOI: 10.1186/s12885-024-12681-0.


Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.

Johansson P, Lind Kristjansdottir H, Johansson H, Mellstrom D, Lewerin C Osteoporos Int. 2024; 35(10):1831-1838.

PMID: 38976026 PMC: 11427511. DOI: 10.1007/s00198-024-07171-9.


References
1.
Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Pettersson-Kymmer U . Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med. 2017; 281(3):300-310. DOI: 10.1111/joim.12586. View

2.
Rajkumar S, Dimopoulos M, Palumbo A, Blade J, Merlini G, Mateos M . International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15(12):e538-48. DOI: 10.1016/S1470-2045(14)70442-5. View

3.
Melton 3rd L, Kyle R, Achenbach S, Oberg A, Rajkumar S . Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res. 2005; 20(3):487-93. DOI: 10.1359/JBMR.041131. View

4.
Ramsenthaler C, Osborne T, Gao W, Siegert R, Edmonds P, Schey S . The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer. 2016; 16:427. PMC: 4937527. DOI: 10.1186/s12885-016-2410-2. View

5.
Blimark C, Turesson I, Genell A, Ahlberg L, Bjorkstrand B, Carlson K . Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 2017; 103(3):506-513. PMC: 5830385. DOI: 10.3324/haematol.2017.178103. View